Codes / ICD10CM / T38.805

T38.805 Adverse effect of unspecified hormones and synthetic substitutes

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of unspecified hormones and synthetic substitutes

Summary

This condition represents adverse effects resulting from exposure to hormones or their synthetic substitutes when the specific agent is not classified elsewhere. It includes reactions to these substances that are not assigned to more specific codes, covering scenarios where the exact hormone or substitute is unspecified. The code captures unintended negative responses to hormonal agents, excluding poisoning or underdosing.

Causes

The causes involve exposure to hormones or their synthetic substitutes, which may result from therapeutic use, accidental ingestion, or incorrect dosing. Adverse effects can arise from the pharmacological properties of these agents, such as off-target interactions or dose-related toxicity, even when administered as intended.

Risk Factors

  • Use of hormone therapies or substitutes for medical conditions
  • Polypharmacy involving hormonal agents
  • Incorrect dosing or administration
  • Individual sensitivity to hormonal substances
  • Renal or hepatic impairment affecting drug metabolism

Symptoms

Symptoms vary based on the specific hormone or agent involved and may include metabolic disturbances, endocrine imbalances, or organ-specific effects. Adverse reactions could manifest as hyper- or hypofunction of target systems, while underdosing may lead to inadequate therapeutic response.

Diagnosis

Diagnosis requires clinical evaluation of symptoms, medication history, and exclusion of other causes. Laboratory tests may assess hormone levels, organ function, or toxicology to identify the underlying agent or mechanism. Documentation should specify the nature of the adverse effect and its relationship to the hormonal agent.

Treatment Options

Treatment focuses on managing symptoms, discontinuing the offending agent, and providing supportive care. Specific interventions depend on the type and severity of the adverse effect, such as electrolyte correction, organ support, or antidotes if available. Monitoring for resolution or progression is essential.

Prognosis and Follow-Up

Prognosis depends on the severity of the adverse effect and timely intervention. Most cases resolve with appropriate management, but some may require long-term monitoring for residual effects. Follow-up ensures symptom resolution and prevents recurrence, particularly if the hormonal agent is continued.

Complications

Complications may include organ damage (e.g., hepatic or renal), persistent endocrine dysfunction, or systemic toxicity. Severe reactions can lead to life-threatening conditions, such as cardiovascular collapse or metabolic crises, requiring intensive care.

Lifestyle & Prevention

Prevention involves proper medication management, including adherence to prescribed dosing, avoiding polypharmacy, and educating patients on potential side effects. Storage and labeling of hormonal products should minimize accidental exposure. Regular monitoring of hormone levels may reduce adverse event risk.

When to Seek Professional Help

Seek immediate medical attention for severe symptoms, such as difficulty breathing, chest pain, or altered consciousness. Persistent or worsening symptoms, even if mild, warrant evaluation to rule out serious complications. Discontinue the suspected agent and report any new or unusual reactions to a healthcare provider.

Tips for Medical Coders

Document the specific adverse effect (e.g., rash, nausea) and its temporal relationship to the hormonal agent. Ensure the code is used only when the agent is unspecified and not classified elsewhere. Include details on exposure context (e.g., therapeutic use) to support coding accuracy.

Book a walkthrough

T38.805 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.